India  
 
NewsR.in

Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

Video Credit: WXYZ Detroit - Duration: 03:49s - Published
Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

Johnson & Johnson’s one-shot vaccine candidate was found to be 85% effective against the most serious symptoms of COVID-19.


You Might Like


Related videos from verified sources

Johnson & Jonson vaccine 66% effective [Video]

Johnson & Jonson vaccine 66% effective

Johnson & Jonson vaccine 66% effective

Credit: FOX 4 Now Florida     Duration: 00:26Published
Healthcare workers stranded in snow give out vaccine doses set to expire [Video]

Healthcare workers stranded in snow give out vaccine doses set to expire

A team of healthcare workers in Oregon stuck in a snowstorm carrying doses of the Covid-19 vaccine that were set to expire set up an impromptu clinic knocking on car windows and vaccinating stranded..

Credit: Bleacher Report AOL     Duration: 03:23Published
Johnson & Johnson's COVID-19 Vaccine Still Has Advantages Despite Less Effectiveness [Video]

Johnson & Johnson's COVID-19 Vaccine Still Has Advantages Despite Less Effectiveness

Overall, Johnson & Johnson's vaccine is 85% effective in preventing severe disease with a single shot.

Credit: CBS 11 Dallas     Duration: 02:10Published